CL

Cheryl Lynn Haughton

Director Director DIN 02920339
DIN 02920339 First appointment Mar 2010 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2010
Shareholding value •••• Premium profile

About Cheryl Lynn Haughton

Data last updated:

Cheryl Lynn Haughton was a Director at Manipal Pharma Private Limited (2010–2013) and Director at Tajucco Pharma Private Limited (2010–2013). The companies operate in Trading and Information Technology.

DIN 02920339
Primary Designation Director
Industry Trading
First Appointment 17 Mar 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Manipal Pharma Private Limited U85100KA2010PTC052866
Director17 Mar 20102010Strike Off
Tajucco Pharma Private Limited U85190KA2010PTC052930
Director22 Mar 20102010₹40.4 Lakh (FY 2019)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Manipal Pharma Private Limited
Tajucco Pharma Private Limited
Premium access

Shareholding and investment profile for Cheryl Lynn Haughton

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cheryl Lynn Haughton

Cheryl Lynn Haughton was first appointed on 17 Mar 2010 as Director at Manipal Pharma Private Limited.

Cheryl Lynn Haughton held 2 earlier board appointments: Manipal Pharma Private Limited (Director, 17 Mar 2010 to 08 Oct 2013); Tajucco Pharma Private Limited (Director, 22 Mar 2010 to 08 Oct 2013).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available